Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$13.87

0.035 (0.25%)

11:20
10/13/17
10/13
11:20
10/13/17
11:20

Horizon Pharmaceuticals with 3X average daily option volume driven by put buying

Horizon Pharmaceuticals with 3X average daily option volume driven by put buying. Shares up a dime to $13.97 and small lots of Feb 10 puts trade from 40 to 50c per contract. 5K trade at that line and the new positions capture earnings in early-November and February.

  • 06

    Nov

HZNP Horizon Pharma
$13.87

0.035 (0.25%)

10/05/17
JEFF
10/05/17
NO CHANGE
Target $16
JEFF
Buy
Horizon's largest potential drug not included in Street models, says Jefferies
Following the "strong" recent Phase 2 results, clinicians believe Horizon Pharma's teprotumumab could become the thyroid eye disease therapy of choice, Jefferies analyst David Steinberg tells investors in a research note titled "'Tepro' Could Be HZNP's Largest Product - but the Street Doesn't Value It." The drug, however, is largely excluded from Street models, the analyst adds. He believes that teprotumumab, if approved, could conservatively research peak sales of $500M, implying 23% upside to the current valuation. Further, if the drug proves to be truly disease-modifying, peak revenue could reach $1.5B, implying 68% upside, Steinberg writes. He feels current therapies for TED are "very limited" and that the drug development pipeline is "lackluster." Steinberg has a Buy rating on Horizon Pharma with a $16 price target.
09/28/17
GSCO
09/28/17
INITIATION
GSCO
Buy
Horizon Pharma initiated with a Buy at Goldman Sachs
Goldman analyst Dana Flanders initiated Horizon Pharma with a Buy and a $16 price target. Flanders said shares have underperformed due to the company's high level of M&A activity but expects strong cash flow generation and capital allocation towards orphan and specialty assets to drive long-term topline growth and margins.
09/27/17
JMPS
09/27/17
NO CHANGE
Target $22
JMPS
Outperform
Horizon Pharma has other patents to protect Ravicti, says JMP Securities
After Lupin won its challenge to Horizon Pharma's '559 patent for Ravicti, JMP Securities analyst Donald Ellis noted that Horizon will appeal the IPR decision, which could take 12-18 months. Also, Ravicti has the recently issued '197 patent, which is unaffected by the '559 decision and extends until 2030, he tells investors. Ellis reiterates his Outperform rating and $22 price target on Horizon Pharma shares, which slid about 2% to $11.95 yesterday following the USPTO ruling.
09/27/17
CANT
09/27/17
NO CHANGE
Target $17
CANT
Overweight
Horizon loss of exclusivity not foregone conclusion, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen does not think it is a forgone conclusion that Horizon Pharma will lose brand exclusivity for Ravicti after the United States Patent and Trademark Office ruled in favor of Lupin regarding the inter partes review of the '559 patent. Ravicti has orphan drug exclusivity that extends to 2020, and multiple other patents protecting the drug, Chen tells investors in a research note. There are no IPRs filed on the '197 patent, which is new, the analyst points out. She still likes shares of Horizon with an Overweight rating and $17 price target.

TODAY'S FREE FLY STORIES

UNP

Union Pacific

$111.94

1.56 (1.41%)

15:50
10/19/17
10/19
15:50
10/19/17
15:50
Options
Union Pacific calls see another day of extraordinary volume »

Union Pacific calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SRC

Spirit Realty

$8.08

-0.39 (-4.60%)

15:49
10/19/17
10/19
15:49
10/19/17
15:49
Hot Stocks
Spirit Realty weakness attributed to report of Sun Capital seeking Shopko buyer »

The weakness in shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

FTR

Frontier Communications

15:45
10/19/17
10/19
15:45
10/19/17
15:45
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CZFC

Citizens First

15:42
10/19/17
10/19
15:42
10/19/17
15:42
Hot Stocks
Citizens First raises semiannual dividend 25% to 10c per share »

On October 19, the Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.15

-0.955 (-3.80%)

15:34
10/19/17
10/19
15:34
10/19/17
15:34
Options
Skechers options imply 14.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BCS

Barclays

$10.16

0.01 (0.10%)

15:31
10/19/17
10/19
15:31
10/19/17
15:31
Periodicals
Barclays being sued for $850M for copper market abuse, Bloomberg reports »

Red Kite Management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

GE

General Electric

$23.72

0.595 (2.57%)

15:30
10/19/17
10/19
15:30
10/19/17
15:30
Options
100K GE Oct 27th 21.5 puts trade ahead of earnings »

100K GE Oct 27th 21.5…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

GE

General Electric

$23.72

0.595 (2.57%)

15:29
10/19/17
10/19
15:29
10/19/17
15:29
Technical Analysis
Technical Earnings Preview: General Electric in well-defined downtrend »

Shares have been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

WFBI

WashingtonFirst

$36.23

-0.25 (-0.69%)

15:28
10/19/17
10/19
15:28
10/19/17
15:28
Earnings
WashingtonFirst reports Q3 core EPS 43c, consensus 41c »

WashingtonFirst President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

15:25
10/19/17
10/19
15:25
10/19/17
15:25
Hot Stocks
Analysis of buyer shopping patterns shows Amazon Prime has 90M members »

Consumer Intelligence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 18

    Mar

PLUG

Plug Power

$2.55

-0.12 (-4.49%)

15:23
10/19/17
10/19
15:23
10/19/17
15:23
Conference/Events
Plug Power to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

HON

Honeywell

$143.65

0.21 (0.15%)

15:21
10/19/17
10/19
15:21
10/19/17
15:21
Technical Analysis
Technical Earnings Preview: Honeywell in bullish channel ahead of earnings »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

ETFC

E-Trade

$43.92

0.14 (0.32%)

15:19
10/19/17
10/19
15:19
10/19/17
15:19
Options
E Trade options imply 4.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 07

    Nov

$NSD

NASDAQ Market Internals

15:17
10/19/17
10/19
15:17
10/19/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
10/19/17
10/19
15:16
10/19/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$159.76

-0.71 (-0.44%)

, HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

15:12
10/19/17
10/19
15:12
10/19/17
15:12
Hot Stocks
Apple drags on Nasdaq after report of reduced iPhone 8 orders »

Shares of Apple (AAPL)…

AAPL

Apple

$159.76

-0.71 (-0.44%)

HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

ISRG

Intuitive Surgical

$354.37

-0.63 (-0.18%)

15:04
10/19/17
10/19
15:04
10/19/17
15:04
Options
Intuitive Surgical options imply 5.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BCS

Barclays

15:03
10/19/17
10/19
15:03
10/19/17
15:03
Periodicals
Breaking Periodicals news story on Barclays »

Red Kite sues Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

DB

Deutsche Bank

$16.88

-0.015 (-0.09%)

15:02
10/19/17
10/19
15:02
10/19/17
15:02
Hot Stocks
Apex Group, Genstar announce acquisition of Deutsche Bank AFS business »

Apex Group and Genstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PG

Procter & Gamble

$91.50

-0.5804 (-0.63%)

15:01
10/19/17
10/19
15:01
10/19/17
15:01
Technical Analysis
Technical Earnings Preview: Procter & Gamble in uptrend before news »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

14:55
10/19/17
10/19
14:55
10/19/17
14:55
General news
Trump already met with Yellen today »

Trump already met with…

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

14:53
10/19/17
10/19
14:53
10/19/17
14:53
Periodicals
Small grocers team up with Amazon to increase sales, Handelsblatt Global says »

Small German grocery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 18

    Mar

AAPL

Apple

$159.76

-0.71 (-0.44%)

14:50
10/19/17
10/19
14:50
10/19/17
14:50
Options
Apple implied volatility reaches 52-week highs »

Apple implied volatility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

PYPL

PayPal

$67.26

0.59 (0.88%)

14:49
10/19/17
10/19
14:49
10/19/17
14:49
Options
PayPal options imply 6.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 29

    Nov

NBR

Nabors Industries

$6.75

-0.325 (-4.60%)

14:45
10/19/17
10/19
14:45
10/19/17
14:45
Options
Nabors Industries call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 15

    May

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.